Comments on: EU Finds Anti-Competitive Abuse Of Pharmaceutical Patents, Launches Antitrust Action

By: EU Finds Anti-Competitive Abuse Of Pharmaceutical Patents, Launches Antitrust Action

Tue, 19 Oct 2010 00:58:10 +0000

[...] Pharmaceutical companies are manipulating the intellectual property rights system and are “activel… [...]

By: Ben Rockwell

Ben Rockwell — Mon, 03 Aug 2009 21:10:34 +0000

What do you expect from them? Have you never heard of the cover-up of annonaceous acetogenins ? Search any database of scientific literature, using the keyword “annonaceous acetogenins”, and you will find hundreds of university studies of these molecules that can be used to make cancerous tumors contract now, with few side effects except a slight risk of tremors. GSK, Novartis, and Pfizer even got an EU subsidy to synthesize these molecules in 2004 at a Cambridge University lab, according to their published study. However, due to the chirality of the acetogenin molecules, they are difficult to synthesize, so they are more practical to extract from the abundant annonaceae plants. Most of all, you cannot patent molecules found in nature, so they dropped the project. They could not synthesize these molecules on a large scale, and they could not patent an extract. What do you expect ?

By: Patents Roundup: Peer-to-Patent Annual Report; FFII, FSFE and IBM Weigh in | Boycott Novell

Thu, 16 Jul 2009 17:15:00 +0000

[...] EU is finally calling pharmaceutical patents anti-competitive and an antitrust action gets launched. How does Bill Gates always manage to find himself doing anti-competitive things and ending up with [...]

By: Surprise, Surprise: Pharma Abusing IP Laws To Prevent Competition | DodaPedia

Fri, 10 Jul 2009 09:10:06 +0000

[...] it should come as no surprise at all that a new report has found that pharmaceutical companies are regularly abusing patents for anti-competitive purposes (thanks Rob Hyndman for the link): Pharmaceutical companies are manipulating the intellectual [...]

By: Web News Site » Blog Archive » Surprise, Surprise: Pharma Abusing IP Laws To Prevent Competition

Thu, 09 Jul 2009 22:49:21 +0000

[...] product development. Thus it should come as no surprise at all that a new report has found that pharmaceutical companies are regularly abusing patents for anti-competitive purposes (thanks Rob Hyndman for the link): Pharmaceutical companies are manipulating the intellectual [...]